Past events
September 6-7, 2022
2cureX presents at LSX Nordic Congress on Biotech, Healthtech & Medtech, Copenhagen, Denmark
June 29 - July 2, 2022
2cureX participates at ESMO in Barcelona, Spain; Booth 210
Exciting feedback from ESMO World Congress on Gastrointestinal Cancer 2022 in Barcelona. Interview with CEO Fernando Andreu and Medical Director Dr. Rafael Gruber.
June 11, 2022
2cureX participates at GI-Oncology in Wiesbaden, Germany
May 24, 2022
Invitation to join the 2cureX Q1 Report webcast and Q&A session at 15:00
May 11, 2022
CSO Ole Thastrup, presents at the Society for Functional Precision Medicine, USA
May 11, 2022
CEO Fernando Andreu, presents at Redeye Theme: Medtech & Diagnostics, Stockholm, Sweden
March 1, 2022 at 14:00 (CET)
Webinar (HC Andersen Capital): Discussion of the Year-End (Q4) 2021 Report
February 25, 2022 at 14:00 (CET)
Webinar (2cureX): Presentation of the Year-End (Q4) 2021 Report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup
February 23, 2022
Fernando Andreu (CEO) and Ole Thastrup (CSO) participation in “Life Science Investor Konference” 23. February 2022, Copenhagen, Denmark
January 26, 2022 at 10:55 (CET)
Mangold Insight Investerardag på tema Life Science - Mangold Fondkommission AB
January 20, 2022
2cureX presents at Redeye Theme – Fight Cancer Seminar – Outlook 2022 (Stockholm, Sweden)
December 9, 2021
2cureX presents at HC Andersen Capital’s Virtual Growth Days (Copenhagen, Denmark)
December 7, 2021
CEO Fernando Andreu will present at ”Sedermeradagen Köbenhamn 2021” (Copenhagen, Denmark)
November 26, 2021 at 13:00 (CET)
Webinar: Presentation of the Q3 report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup
November 18, 2021
Presentation by Fernando Andreu (CEO) and Ole Thastrup (CSO) at the Investor-week by the Dansk Shareholder’s Association
November 15, 2021
Presentation by Ole Thastrup (CSO 2cureX) at the TechConnect Europe Innovation Conference & Expo (Malmø, Sweden)
October 21, 2021
Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)
October 5, 2021 at 15:00 (CET)
Precision Oncology Webinar: Beyond Biomarkers. Clinical Peers (Dr. John Lindsay Marshall, from Georgetown University Hospital, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain and Dr. Lars Henrik Jensen, University Hospital Vejle, DK) present the role of the functional test IndiTreat® in personalized oncology to oncologists and 2cureX’s Distributors (promoted on Oncology Convention website, UK. Open participation.
September 23, 2021
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
September 15, 2021 at 15:00 (CET)
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
September 12, 2021 at 13:00 (CET)
Strategy update Webinar. CSO Fernando Andreu, CSO Ole Thastrup, VP Business Development Pia van der Zee and VP Sales Jesper F. Kristiansen provide a strategy update to investors, analysts, and media.
August 27, 2021 at 14:00 (CET)
Webinar: Presentation of the Q2 report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup
February 10, 2021
VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich
July 1, 2020
World Congress on Gastrointestinal Cancer, ESMO GI, Barcelona, Spain - VIRTUAL
February 19-22, 2020
German Cancer Congress, 34 Deutscher Krebs Kongress 2020, Berlin, Germany
September 27 – October 1, 2019
Barcelona, ESMO (Eur. Soc. Medical Oncology) congress 2019: Translating science into better cancer patient care